Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T3722 |
MK-1064
Urokinase inhibitor 1,MK 1064 |
OX Receptor | GPCR/G Protein; Neuroscience |
MK-1064 (Urokinase inhibitor 1) 是一种选择性食欲素 2 (2-SORA)受体拮抗剂,可用于失眠患者的研究。 | |||
T13408 |
ZK824190
|
Others; Serine Protease | Others; Proteases/Proteasome |
ZK824190 是具有口服活性尿激酶型纤溶酶原激活剂 (uPA) 选择性抑制剂,对 uPA,tPA 和 Plasmin 的IC50分别为 237,1600 和 1850 nM。ZK824190在多发性硬化症中有研究价值。 | |||
T60248 |
4-Aminobenzamidine dihydrochloride
p-Aminobenzamidine dihydrochloride |
Serine Protease | Proteases/Proteasome |
4-Aminobenzamidine dihydrochloride (p-Aminobenzamidine dihydrochloride) 是一种强胰蛋白酶 (trypsin)抑制剂,也是一种相对较弱的尿激酶型纤溶酶原激活剂 (uPA) 抑制剂 (Ki=82 μM)。4-Aminobenzamidine 可抑制 SCID 小鼠体内前列腺肿瘤的生长。 | |||
T13251 |
UKI-1
UKI-1C |
Others | Others |
UKI-1 is a urokinase-type plasminogen activator system synthetic inhibitor. | |||
T35931 |
GGACK (hydrochloride)
|
||
GGACK is an inhibitor of urokinase-type plasminogen activator (uPA) and factor Xa (Kis = 1.8 and 8.7 μM, respectively).1,2 1.Kettner, C., and Shaw, E.The susceptibility of urokinase to affinity labeling by peptides of arginine chloromethyl ketoneBiochim. Biophys. Acta569(1)31-40(1979) 2.Kettner, C., and Shaw, E.The selective affinity labeling of factor Xa by peptides of arginine chloromethyl ketoneThromb. Res.22(5-6)645-652(1981) | |||
T80859 |
Vitronectin
|
||
Vitronectin为一类多功能糖蛋白,广泛分布于血液及细胞外基质。该蛋白质与糖胺聚糖、胶原蛋白、纤溶酶原及尿激酶受体发生结合,并对纤溶酶原激活抑制剂1的抑制构象起稳定作用。Vitronectin常用于促进伤口愈合和肿瘤进展研究领域。 |